MedTrace Logo

Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy

NCT00632190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2010-01-28

No results posted yet for this study

Summary

RATIONALE: New diagnostic procedures, such as spectroscopy, may be a less invasive way to check for dysplasia and neoplasia in the cervix. Spectroscopy may also used as a screening test to help doctors find cervical cancer sooner, when it may be easier to treat.

PURPOSE: This clinical trial is studying how well spectroscopy works in diagnosing dysplasia and neoplasia in the cervix in women undergoing colposcopy or Pap testing.

Conditions

Interventions

OTHER

fluorophotometry

PROCEDURE

colposcopic biopsy

PROCEDURE

colposcopy

PROCEDURE

light-scattering spectroscopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • British Columbia Cancer Agency

    lead OTHER

Principal Investigators

  • Sylvia Lam · British Columbia Cancer Agency

Study Design

Purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2003-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00632190 on ClinicalTrials.gov